These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 33743046)

  • 1. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
    Aamodt AH; Høgestøl EA; Popperud TH; Holter JC; Dyrhol-Riise AM; Tonby K; Stiksrud B; Quist-Paulsen E; Berge T; Barratt-Due A; Aukrust P; Heggelund L; Blennow K; Zetterberg H; Harbo HF
    J Neurol; 2021 Oct; 268(10):3574-3583. PubMed ID: 33743046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
    Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
    Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Huang Z; Haile K; Gedefaw L; Lau BW; Jin L; Yip SP; Huang CL
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
    J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
    Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
    Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
    Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
    Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
    Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
    Kanberg N; Ashton NJ; Andersson LM; Yilmaz A; Lindh M; Nilsson S; Price RW; Blennow K; Zetterberg H; Gisslén M
    Neurology; 2020 Sep; 95(12):e1754-e1759. PubMed ID: 32546655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
    Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
    J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
    Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
    Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
    Bark L; Larsson IM; Wallin E; Simrén J; Zetterberg H; Lipcsey M; Frithiof R; Rostami E; Hultström M
    Sci Rep; 2023 Aug; 13(1):13144. PubMed ID: 37573366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.
    Yin P; Niu X; Guan C; Zhang Z; Liu Y; Li J; Cui G; Zan K; Xu C
    Psychogeriatrics; 2024 Mar; 24(2):415-425. PubMed ID: 38339819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort.
    Stukas S; Cooper J; Higgins V; Holmes D; Adeli K; Wellington CL
    Clin Chem Lab Med; 2024 Mar; 62(4):698-705. PubMed ID: 37882772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
    Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
    J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
    Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
    J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients.
    De Lorenzo R; Loré NI; Finardi A; Mandelli A; Cirillo DM; Tresoldi C; Benedetti F; Ciceri F; Rovere-Querini P; Comi G; Filippi M; Manfredi AA; Furlan R
    J Neurol; 2021 Dec; 268(12):4436-4442. PubMed ID: 33973106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.